Source: Health Canada shortage reports · Updated Oct 19, 2026
Also sold as: Movisse, Micronor, Maeve, Jencycla
Norethindrone has no current shortage reported in Canada. It has been in shortage before; the history is below.
A progestin hormone used for birth control and menstrual conditions.
Products affected
0 / 4
Reports on file
14
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
MAEVE
0.35MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02458683 · ended Sep 29, 2026 · Disruption of the manufacture of the drug.
To be discontinued
MAEVE
0.35MG · TABLET · GLENMARK PHARMACEUTICALS CANADA INC.
DIN 02458683
Resolved
MOVISSE
0.35MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410303 · ended Jul 6, 2022 · Disruption of the manufacture of the drug.
Resolved
MOVISSE
0.35MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410303 · ended Dec 30, 2021 · Demand increase for the drug.
To be discontinued
MICRONOR TABLETS 28-DAY
0.35MG · TABLET · JANSSEN INC
DIN 00037605
To be discontinued
MICRONOR TABLETS 28-DAY
0.35MG · TABLET · JANSSEN INC
DIN 00037605
Resolved
MOVISSE
0.35MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410303 · ended Apr 28, 2020 · Demand increase for the drug.
Resolved
MOVISSE
0.35MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410303 · ended Feb 25, 2020 · Delay in shipping of the drug.
Resolved
MOVISSE
0.35MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410303 · ended Jan 22, 2020 · Delay in shipping of the drug.
Resolved
JENCYCLA
0.35MG · TABLET · LUPIN PHARMA CANADA LIMITED
DIN 02441306 · ended Jan 21, 2020 · Demand increase for the drug.
Resolved
MOVISSE
0.35MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410303 · ended Aug 30, 2019 · Requirements related to complying with good manufacturing practices.
Avoided
MOVISSE
0.35MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02410303 · ended Feb 9, 2018 · Delay in shipping of the drug.
Showing 12 of 14 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Norethindrone. Health Canada has 14 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Norethindrone is classified under “HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE” (ATC G03AC).
Recent changes
Oct 19, 2026
Shortage resolved
Sep 29, 2026
New report filed
Sep 29, 2026
Estimated end date moved earlier : null → Sep 29, 2026
Common questions
What is Norethindrone used for?
A progestin hormone used for birth control and menstrual conditions.
When will Norethindrone be back in stock in Canada?
Norethindrone has no active shortage; supply is normal per Health Canada reports.
Why is Norethindrone in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.